PTC Therapeutics, Inc.
PTCT
$48.19
$0.000.00%
NASDAQ
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | 57.71% | 19.79% | 50.13% | 34.10% | 8.83% |
| Total Depreciation and Amortization | -91.62% | -89.55% | -86.24% | 29.35% | 107.65% |
| Total Amortization of Deferred Charges | 2.68% | -47.64% | -47.60% | -32.42% | -48.89% |
| Total Other Non-Cash Items | -113.60% | -73.00% | -68.66% | 49.64% | 1,588.40% |
| Change in Net Operating Assets | 144.28% | 30.99% | -134.51% | 69.21% | -169.20% |
| Cash from Operations | 70.08% | -430.28% | -406.04% | 339.94% | 39.57% |
| Capital Expenditure | 32.32% | 91.79% | 218.09% | 6.64% | 35.44% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 405.54% | -81.47% | -478.83% | -463.31% | -316.39% |
| Cash from Investing | 383.54% | -44.19% | -177.55% | -296.71% | -391.06% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | 100.00% | -- | -- | -8.05% | -- |
| Issuance of Common Stock | 994.75% | -83.37% | -74.61% | -64.10% | -49.33% |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -100.00% | -21,311.76% | 1,612,046.67% | -- | 1,870.48% |
| Cash from Financing | -95.73% | -624.46% | 1,235.22% | -86.81% | 104.84% |
| Foreign Exchange rate Adjustments | -379.58% | 466.30% | -150.29% | 74.51% | -48.59% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -40.42% | -198.83% | 1,242.22% | 26.74% | 144.49% |